SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-032871
Filing Date
2024-02-13
Accepted
2024-02-13 07:01:03
Documents
14
Period of Report
2024-02-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d780523d8k.htm   iXBRL 8-K 23248
  Complete submission text file 0001193125-24-032871.txt   141115

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA alrn-20240209.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE alrn-20240209_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alrn-20240209_pre.xml EX-101.PRE 10816
16 EXTRACTED XBRL INSTANCE DOCUMENT d780523d8k_htm.xml XML 3574
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38130 | Film No.: 24622555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)